Fundraising Fox

Nucleix

7 known investors

Nucleix is a healthcare company developing diagnostic technology based on DNA/nucleic acid analysis for cancer detection. It serves the medical diagnostics and biotechnology market.

BiotechDigital HealthHealthtechMedical Devices

Founders & leadership

EF
Eli FrydmanPresident EMEA

Investors · 7

Gefen CapitalHerzliya Pituach
OrbiMedNew York · $1M – $75M
RA CapitalBoston
BlackRockreported · 2 sourcesWilmington
Lilly Asia Venturesreported · 2 sourcesHong Kong
LYFE Capitalreported · 2 sourcesMenlo Park
Sands Capital VenturesreportedArlington · $10M – $30M

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Nucleix Raises Additional $22M - NewsBreaknewsbreak.com · Jan 2022Nucleix Raises $55M for Early Detection of Lung Cancer - San Diego Business Journalsdbj.com · Apr 2021Nucleix knuckles down to raise $55m - Global Venturingglobalventuring.com · Apr 2021Liquid biopsy maker Nucleix rakes in $55M to develop blood tests to detect lung cancer early | Fierce Biotechfiercebiotech.com · Apr 2021Nucleix Secures $55M in Funding - FinSMEsfinsmes.com · Apr 2021Cancer Screening Company Nucleix Raises 2.5 Million Euros - CTechcalcalistech.com · Jul 2018

Frequently asked questions

What does Nucleix do?
Nucleix is a healthcare company developing diagnostic technology based on DNA/nucleic acid analysis for cancer detection. It serves the medical diagnostics and biotechnology market.
Who are Nucleix's investors?
Nucleix's investors include Gefen Capital, OrbiMed, RA Capital, BlackRock, Lilly Asia Ventures, LYFE Capital, Sands Capital Ventures.